Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,048 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

NCT02273739

Conditions
Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Miami, Florida, United States
  • Baltimore, Maryland, United States
View Trial Details
Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

NCT00541008

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Centre Paul Papin Angers, France
  • Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besançon, France
  • Hopital Saint Andre Bordeaux, France
  • C.H.U. de Brest Brest, France
View all 22 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

NCT00003683

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Institut Sainte Catherine Avignon, France
  • Centre Leon Berard Lyon, France
  • Institut J. Paoli and I. Calmettes Marseille, France
  • Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France
View all 14 locations
View Trial Details
Completed

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

NCT01835158

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
View all 488 locations
View Trial Details

Related conditions